Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Bristol-Myers Squibb and Pierre Fabre terminate license agreement for vinflunine

Nov. 26, 2007

FDA approves Bionomics' IND application for anticancer compound BNC-105

Nov. 26, 2007

Recent patents divulge new therapeutic agents for cancer

Nov. 26, 2007

Hana initiates phase II clinical trial of Marqibo for metastatic malignant uveal melanoma

Nov. 23, 2007

Merck & Co. suspends enrollment in clinical trials of kinase inhibitor MK-0457

Nov. 23, 2007

Antisoma provides update on clinical development of its anticancer compounds

Nov. 22, 2007

Preclinical profile of novel oncolytic measles virus

Nov. 22, 2007

FDA approves supplemental NDA for Nexavar for unresectable hepatocellular carcinoma

Nov. 20, 2007

Thallion reports positive safety and efficacy data from phase I/II trial of ECO-4601

Nov. 20, 2007

Adventrx meets primary endpoint in bioequivalence clinical study of ANX-530

Nov. 20, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...